Array study in fetuses with nuchal translucency above the 95th percentile: a 4-year observational single-centre study-Reference-Cited by-同舟云学术

Array study in fetuses with nuchal translucency above the 95th percentile: a 4-year observational single-centre study

Published:2022-04-29 Issue:1 Volume:307 Page:285-292
ISSN:1432-0711
Container-title:Archives of Gynecology and Obstetrics
language:en
Short-container-title:Arch Gynecol Obstet

Author:

Coello-Cahuao Edgar,Sánchez-Durán María Ángeles^ORCID,Calero Inés,Higueras María Teresa^ORCID,García Mayte Avilés^ORCID,Rodó Carlota^ORCID,Maiz Nerea^ORCID,Plaja Rustein Alberto^ORCID,Castells-Sarret Neus^ORCID,Mediano-Vizuete Carmen,Carreras Elena^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynecology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00404-022-06564-7.pdf

Reference38 articles.

1. Souka AP, Von Kaisenberg CS, Hyett JA et al (2005) Increased nuchal translucency with normal karyotype. Am J Obstet Gynecol 192:1005–1021. https://doi.org/10.1016/j.ajog.2004.12.093

2. Baer RJ, Norton ME, Shaw GM et al (2014) Risk of selected structural abnormalities in infants after increased nuchal translucency measurement. Am J Obstet Gynecol 211:675.e1–19. https://doi.org/10.1016/j.ajog.2014.06.025

3. Kagan KO, Sonek J, Kozlowski P (2022) Antenatal screening for chromosomal abnormalities. Arch Gynecol Obstet 305:825–835. https://doi.org/10.1007/s00404-022-06477-5

4. Hellmuth SG, Pedersen LH, Miltoft CB et al (2017) Increased nuchal translucency thickness and risk of neurodevelopmental disorders. Ultrasound Obstet Gynecol 49:592–598. https://doi.org/10.1002/uog.15961

5. Wapner RJ, Martin CL, Levy B et al (2012) Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med 367:2175–2184. https://doi.org/10.1056/NEJMoa1203382

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chromosomal Microarray Analysis in Fetuses with Ultrasound Abnormalities;International Journal of General Medicine;2024-08

2. Is Nuchal Translucency of 3.0–3.4 mm an Indication for cfDNA Testing or Microarray? – A Multicenter Retrospective Clinical Cohort Study;Fetal Diagnosis and Therapy;2024

3. 16p13.11 microdeletion/microduplication in fetuses: investigation of associated ultrasound phenotypes, genetic anomalies, and pregnancy outcome follow-up;BMC Pregnancy and Childbirth;2022-12-07

4. ISPD 2022 debate—When offering a first trimester ultrasound at 11 + 0 to 13 + 6 weeks, a detailed review of fetal anatomy should be included;Prenatal Diagnosis;2022-11-03